Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. (DBTX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DBTX · as of Dec 31, 2023
Ownership Breakdown
1
Institutional Holders
$36,400
Total Inst. Value
25.13M
Shares Outstanding
freeFloat 53.32%
40,000
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DBTX largest shareholders · institutional ownership
Q4 2023 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ATLAS CAPITAL ADVISORS LLC pharmaceutical preparations | 40.0K | 15.99% | 15.99% | $36.40M | Feb 15, 2024 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2023 vs prior quarter
Q4 2023
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DBTX insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
29
Sell transactions
0.00
Buy/Sell ratio
$3M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Trask Anna Chief People Officer | Sep 25, 2023 | D-Return | 106,864 | $3.50 | $374.0K | 0 | Form 4 ↗ |
Trask Anna Chief People Officer | Sep 25, 2023 | D-Return | 45,000 | $3.12 | $140.4K | 0 | Form 4 ↗ |
Trask Anna Chief People Officer | Sep 25, 2023 | D-Return | 52,500 | $3.50 | $183.8K | 0 | Form 4 ↗ |
Trask Anna Chief People Officer | Sep 25, 2023 | D-Return | 137,302 | $4.40 | $604.1K | 0 | Form 4 ↗ |
Carson William H. director | Sep 25, 2023 | D-Return | 10,000 | $2.30 | $23.0K | 0 | Form 4 ↗ |
Carson William H. director | Sep 25, 2023 | D-Return | 5,000 | $3.50 | $17.5K | 0 | Form 4 ↗ |
Carson William H. director | Sep 25, 2023 | D-Return | 5,000 | $4.78 | $23.9K | 0 | Form 4 ↗ |
Carson William H. director | Sep 25, 2023 | D-Return | 20,000 | $8.42 | $168.4K | 0 | Form 4 ↗ |
Lee John Jui-Jen Chief Development Officer | Sep 25, 2023 | D-Return | 147,144 | $3.50 | $515.0K | 0 | Form 4 ↗ |
Lee John Jui-Jen Chief Development Officer | Sep 25, 2023 | D-Return | 45,000 | $3.12 | $140.4K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Decibel Therapeutics, Inc. (DBTX) is primarily owned by institutional investors, who hold approximately 0.2% of total shares outstanding. Company insiders own approximately 46.68%, while retail and public investors account for the remaining 53.16%.
The largest institutional shareholder of Decibel Therapeutics, Inc. is ATLAS CAPITAL ADVISORS LLC, holding approximately 40,000 shares — equal to 15.99% of outstanding shares — as of December 31, 2023.
A total of 1 institutional investors currently hold DBTX stock, with a combined institutional value of approximately $36,400 as of the most recent 13F filing period.
Frequently asked questions
DBTX ownershipDecibel Therapeutics, Inc. (DBTX) is primarily owned by institutional investors, who hold approximately 0.2% of shares. The largest shareholder is ATLAS CAPITAL ADVISORS LLC with a 15.99% stake. Company insiders hold 46.68%. Data sourced from SEC Form 13F as of December 31, 2023.